A Multidisciplinary Approach in a Community Pharmacy Can Improve Outcomes for Diabetes Patients

Abstract

Get full access to this article

View all access options for this article.

References

1. American Diabetes Association . Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2000; 23:S32-S42.

2. Coonrod BA , Harris Ml , Betschart J. Frequency and determinants of diabetes patient education among adults in the U.S. population. Diabetes Care. 1994;17: 852-858.

3. US Department of Health and Human Services . Healthy People 2010. Washington, DC: US Government Printing Office; 2000.

4. Berringer R , Shibley S , Cary C , Pugh C , Powers E , Rafi J. Outcomes of a community pharmacybased diabetes monitoring program. J Am Pharm Assoc. 1999; 39:791-797.

5. Kelly C , Rodgers PT . Implementation and evaluation of a pharmacist-managed diabetes service. J Manage Care Pharm. 2000;6:488-493.

6. The Asheville Project . Pharm Times. 1998 (October supplement).

7. Nau DP , Ponte CD . Effects of a community pharmacist-based diabetes patient-management program on intermediate clinical outcome measures. J Manage Care Pharm. 2002;8: 48-53.

8. West D. Providing diabetes education in a community pharmacy. Ark Pharmacist. 2002; Spring:21-23.

9. Arkansas Diabetes Control Program . A Look at Diabetes in Arkansas (2002). Available at: http://www.healthyarkansas.com/services/pdf/diabetesark2002.PDF. Accessed December 10, 2002.

10.

10. American Diabetes Association . Education Recognition Program. Available at: http://www.diabetes.org/main/professional/recognition/erp/jsp. Accessed January 10, 2003.

11.

11. Centers for Disease Control and Prevention . Behavioral risk factor surveillance system. Diabetes surveillance system: prevalence of diabetes, 1994-2000. Available at: http://www.cdc.gov/diabetes/statistics/prev/state/Table%5D6.htm. Accessed January 10, 2003.

12.

12. Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14): 977-986.

13.

13. UK Prospective Diabetes Study (UKPDS) Group . Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352: 837-853.